Patel Archana B, Dhande Leena A, Rawat Manwar S
Clinical Epidemiology Unit, Indira Gandhi Medical College, Nagpur 440 018, Maharashtra, India.
Indian Pediatr. 2005 May;42(5):433-42.
To test the hypothesis that daily supplementation of zinc and copper mixed with the oral rehydration solution (ORS) reduces the duration and the severity of acute diarrhea in children.
In a randomized, double blind, placebo controlled trial children aged 6 months to 59 months in an urban hospital with acute diarrhea, were assigned to receive the intervention of once daily 40 mg of zinc sulfate and 5 mg of copper sulfate dissolved in a liter of standard ORS (n = 102) or placebo (50 mg of standard ORS powder) dissolved in a liter of ORS (n = 98).
The baseline characteristics in the two groups were similar. The mean survival time (days) (SE) with diarrhea was not significantly different in the treatment (4.34 (0.2)) as compared to the placebo group (4.48 (0.2)), nor was there any difference in the median time to cure. Cure was less likely with longer duration of diarrhea prior to enrollment (P < 0.001), if the time taken for rehydration was more (P = 0.001) and if intravenous fluids were used (P = 0.03) regardless of the micronutrient supplementation. The proportion of children with diarrhea > 4 days was 46% in the placebo group with an adjusted odds ratio (OR) (95% CI) of 1.19 (1.58, 0.9; P = 0.2) as compared to 39% in the supplemented group. The most important risk factor for diarrhea > 4 days was diarrheal duration prior to enrollment with OR = 6.25 (3.7, 11.1). The supplemented group however had less severity of diarrhea with a lower proportion of children requiring unscheduled intravenous fluids (OR = 0.4; 95% CI 0.05, 2.2), with weight loss (OR = 0.7; 95% CI; 0.4, 1.3), with complications (OR = 0.15; 0.01, 1.3) and had no deaths as compared to two in the placebo group.
This study showed that the most important predictor for duration of diarrhea in children was the severity of the disease at enrollment, and, not the supplementation. There were clinical beneficial effects of supplementation on rate of any complications and mortality. A larger trial is warranted before supplementation of micronutrients mixed with ORS are recommended for management of acute diarrhea.
验证以下假设,即每日在口服补液盐(ORS)中添加锌和铜可缩短儿童急性腹泻的病程并减轻其严重程度。
在一项随机、双盲、安慰剂对照试验中,一家城市医院里6个月至59个月患有急性腹泻的儿童被分配接受以下干预措施:每日一次将40毫克硫酸锌和5毫克硫酸铜溶解于一升标准ORS中(n = 102),或每日一次将50毫克标准ORS粉剂(安慰剂)溶解于一升ORS中(n = 98)。
两组的基线特征相似。治疗组腹泻的平均存活时间(天数)(标准误)为4.34(0.2),与安慰剂组的4.48(0.2)相比无显著差异,治愈的中位时间也无差异。无论是否补充微量营养素,入组前腹泻持续时间越长(P < 0.001)、补液所需时间越长(P = 0.001)以及使用静脉输液(P = 0.03),治愈的可能性越低。安慰剂组腹泻超过4天的儿童比例为46%,调整后的优势比(OR)(95%置信区间)为1.19(1.58,0.9;P = 0.2),而补充组这一比例为39%。腹泻超过4天的最重要风险因素是入组前的腹泻持续时间,OR = 6.25(3.7,11.1)。然而,补充组腹泻的严重程度较低,需要非计划静脉输液的儿童比例较低(OR = 0.4;95%置信区间0.05,2.2),体重减轻的比例较低(OR = 0.7;95%置信区间;0.4,1.3),出现并发症的比例较低(OR = 0.15;0.01,1.3),且无死亡病例,而安慰剂组有2例死亡。
本研究表明,儿童腹泻持续时间的最重要预测因素是入组时疾病的严重程度,而非补充微量营养素。补充微量营养素对任何并发症发生率和死亡率有临床有益影响。在推荐将微量营养素与ORS混合用于治疗急性腹泻之前,有必要进行更大规模的试验。